FDA DEVICE FACTS
TranS1 AxiaLIF Plus System
Trans1
Verified FDA Record identity for medical-device development research. This overview uses only fields stated in the FDA Record and is not a Device Description.医療機器開発の調査用に、確認済みの FDA Record の識別情報を示しています。この概要は FDA Record に記載された項目だけによるもので、機器説明ではありません。
Indications for use
TranS1 AxiaLIF Plu s System is intended to provide anterio r stabilization of the L5-S1 or L4 -S1 spinal segment(s) as an adjunct to spinal fusion. Th e AxiaLIF Plus System is indicated for patients requiring fu sion to treat pseudoarthrosis (unsuccessful previous fusion), spinal steno sis, spondylolisthesis (Grade 1 or 2 if single-level; Grade 1 if two-level), o r degenerative disc disease as defined as back pain of discogenic origin with deg eneration of the disc confirmed by history and radiographic studies. Its usage is limited to anterior supplemen tal fixation of the lumbar spine at L5-S1 or L4-S1 in conjunction with legally marketed facet screw or pedicle screw systems at the same levels th at are treated with AxiaLIF.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。